🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Matching placebo to sitagliptin

Found 73 matching trials

Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)

PHASE1

A clinical study to determine the safety, efficacy and the way sitagliptin ...

Status

Completed

Location

Multiple Locations

Start Date

2007-02-14

Trial ID

NCT00704132

Treatments Being Tested

Comparator: sitagliptin phosphate Comparator: placebo (unspecified)

Efficacy and Safety of Albiglutide in Treatment of Type 2 Diabetes

PHASE3

The purpose of this study is to determine if albiglutide is safe and effect...

Status

Completed

Location

GSK Investigational Site

Start Date

2009-02

Trial ID

NCT00838903

Treatments Being Tested

albiglutide sitagliptin glimepiride metformin placebo albiglutide placebo sitagliptin placebo glimepiride

A Study to Test the Effectiveness and Safety of MK0893 in Combination With Other Drugs Used to Treat Type 2 Diabetes (0893-015)

PHASE2

This study will test the effectiveness and safety of treatment with MK-0893...

Status

Completed

Location

Multiple Locations

Start Date

2008-02

Trial ID

NCT00631488

Treatments Being Tested

MK-0893 Sitagliptin Metformin Placebo for MK-0893 Placebo for Sitagliptin Placebo for Metformin

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of K-757 in Healthy Overweight/Obese Volunteers

PHASE1

This is a multiple dose study to evaluate the safety, tolerability, PK, and...

Status

Completed

Location

ProSciento, Inc.

Start Date

2022-09-21

Trial ID

NCT05900531

Treatments Being Tested

K-757 K-757 and open-label sitagliptin Matching placebo to K-757 Matching placebo to K-757 and matching placebo to K-833 K-757 and K-833 Matching placebo to K-757, open-label sitagliptin

A Study to Evaluate the Efficacy and Safety of Sitagliptin and MK0431A in Comparison to a Commonly Used Medication in Patients With Type 2 Diabetes (0431-068)(COMPLETED)

PHASE3

The purpose of this study is to evaluate the efficacy and safety of sitagli...

Status

Completed

Location

Multiple Locations

Start Date

2008-01-15

Trial ID

NCT00541450

Treatments Being Tested

Comparator: sitagliptin phosphate (sitagliptin)sitagliptin phosphate (+) metformin hydrochloride Comparator: pioglitazone Matching placebo to pioglitazone Matching placebo to sitagliptin Matching Placebo to Sita/Met FDC

Evaluation of the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type 2 Diabetes

PHASE3

This study is being carried out to see if dapagliflozin in addition to metf...

Status

Completed

Location

Research Site

Start Date

2009-02

Trial ID

NCT00855166

Treatments Being Tested

Dapagliflozin Metformin Sitagliptin Placebo

TAK-875 (Fasiglifam) in Combination With Sitagliptin in Adults With Type 2 Diabetes

PHASE3

The purpose of this study is to evaluate the effect of TAK-875 (fasiglifam)...

Status

Terminated

Location

Multiple Locations

Start Date

2013-05

Trial ID

NCT01829464

Treatments Being Tested

Placebo TAK-875 TAK-875

Study to Evaluate the Efficacy and Safety of Saxagliptin Co-administered With Dapagliflozin in Combination With Metformin Compared to Sitagliptin in Combination With Metformin in Adult Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control on Metformin Therapy Alone

PHASE3

Study will evaluate if a combination of saxagliptin and dapagliflozin added...

Status

Completed

Location

Research Site

Start Date

2014-09-09

Trial ID

NCT02284893

Treatments Being Tested

Saxagliptin Dapagliflozin Sitagliptin Placebo matching with Saxagliptin Placebo matching with Dapagliflozin Placebo matching with Sitagliptin

A Study of the Co-administration of Sitagliptin and Atorvastatin in Inadequately Controlled Type 2 Diabetes Mellitus (MK-0431E-211)

PHASE3

This two-phase study was to examine if 16 weeks of treatment with sitaglipt...

Status

Terminated

Location

Multiple Locations

Start Date

2011-10-24

Trial ID

NCT01477853

Treatments Being Tested

Sitagliptin Atorvastatin Placebo to sitagliptin Placebo to atorvastatin Metformin (open-label)Glimepiride (open-label)Glimepiride (double-blind)Placebo to glimepiride

A Phase 2 Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus (T2DM)

The objectives of the study is to evaluate the efficacy, safety, and dose o...

Status

Completed

Location

Heishinkai Medical Group Incorporated OCROM Clinic

Start Date

2015-11

Trial ID

NCT02628392

Treatments Being Tested

DS-8500a Sitagliptin placebo

Previous Next